Prevalence of Human T Cell Lymphotropic Virus 1 Infection in Canada
Excerpt
Human T cell lymphotropic virus 1 (htlv-1) is a bloodborne retrovirus that infects at least 5–20 million people around the world [...]
Share and Cite
Amar, L.; Le, M.; Ghazawi, F.M.; Rahme, E.; Segal, A.; Netchiporouk, E.; Popradi, G.; Moreau, L.; Roshdy, O.; Sasseville, D.; et al. Prevalence of Human T Cell Lymphotropic Virus 1 Infection in Canada. Curr. Oncol. 2019, 26, 3-5. https://doi.org/10.3747/co.26.4593
Amar L, Le M, Ghazawi FM, Rahme E, Segal A, Netchiporouk E, Popradi G, Moreau L, Roshdy O, Sasseville D, et al. Prevalence of Human T Cell Lymphotropic Virus 1 Infection in Canada. Current Oncology. 2019; 26(1):3-5. https://doi.org/10.3747/co.26.4593
Chicago/Turabian StyleAmar, L., M. Le, F. M. Ghazawi, E. Rahme, A. Segal, E. Netchiporouk, G. Popradi, L. Moreau, O. Roshdy, D. Sasseville, and et al. 2019. "Prevalence of Human T Cell Lymphotropic Virus 1 Infection in Canada" Current Oncology 26, no. 1: 3-5. https://doi.org/10.3747/co.26.4593